|
| |
autoimmune pharmaceuticals AI 401 Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - autoimmune pharmaceuticals AI 401
autoimmune pharmaceuticals AI 401 Pages on BioPortfolio: ... BioPortfolio autoimmune pharmaceuticals AI 401 Multiple sclerosisMS is an autoimmune ...
http://www.bioportfolio.com/search/autoimmune_pharmaceutical...
|
AutoImmune, Inc. Reports 2007 First Quarter Financial Results ...
Biotech and Pharmaceutical News & Jobs. Search the Site ... The NIH has started a multicenter Phase III trial on our product, AI-401, to determine if ...
http://www.biospace.com/news_story.aspx?NewsEntityId=55881...
|
BioPortfolio - AutoImmune Incorporated - Profile
pharmaceutical productsfor the treatment of autoimmune and other cell-mediated ... A third product, AI 401, for the treatment of Type 1 diabetes, ...
http://www.bioportfolio.com/biocorporate/413-AutoImmune%2BIn...
|
To Our Shareholders: 2007
As long term shareholders well know, AutoImmune has licensed two applications ... treatment with our product, AI 401, can delay or prevent Type 1 diabetes.
...
http://www.autoimmuneinc.com/News/letters/2007.html...
|
Chronic Pancreatitis
Autoimmune pancreatitis: more than just a pancreatic disease? .... Bank S, Marks IN, Vinik AI. Clinical and hormonal aspects of pancreatic diabetes. ...
http://www.medscape.com/viewarticle/543066_12...
|
In The Clinic - MS Technology
AutoImmune will receive a $10 million milestone payment upon product approval and escalating royalties ... Colloral® | MS Technology | AI-401 | Clinical
Papers.
http://www.autoimmuneinc.com/clinic/myloral.html...
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
disorders and autoimmune diseases, primarily in the development of Copaxone ...... be qualified under Section 401(a) of the Code has received a favorable
...
http://www.tevapharm.com/pdf/F4-240905.pdf...
|
Expression of the Chemokine Receptors CCR4, CCR5, and CXCR3 by ...
Interestingly, lymphocytes from the synovial fluid of autoimmune arthritis ..... AI-47822, GM-56527 and AI-37832 and a Merit Award from the Veterans ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
Complement-targeted therapeutics : Article : Nature Biotechnology
Complement seems to be a major contributor to a number of autoimmune diseases. ..... Alexion Pharmaceuticals has therefore announced that it plans to focus ...
http://www.nature.com/nbt/journal/v25/n11/full/nbt1342.html...
|
Third quarter 2005 Basel, October 19, 2005
Autoimmune diseases: phase. III in lupus nephritis started. (Aspreva). all growth rates are local ..... Top 20 products by region – Pharmaceuticals
Division ...
http://www.roche.com/irp3q05e.pdf...
|
|
